Immunome Inc. has granted nonstatutory stock options to purchase a total of 19,000 shares of common stock to three new employees under its 2024 Inducement Plan. Each stock option has an exercise price of $17.00 per share, matching the company's closing sales price on November 3, 2025. The options will vest over four years, with 25% vesting after the first year and the remaining shares vesting monthly over the following 36 months, contingent on continued employment with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251104568267) on November 04, 2025, and is solely responsible for the information contained therein.